<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR190">
 <label>190.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gibney</surname>
    <given-names>GT</given-names>
   </name>
   <name>
    <surname>Hamid</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Lutzky</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Olszanski</surname>
    <given-names>AJ</given-names>
   </name>
   <name>
    <surname>Mitchell</surname>
    <given-names>TC</given-names>
   </name>
   <name>
    <surname>Gajewski</surname>
    <given-names>TF</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma</article-title>
  <source>J Immunother Cancer</source>
  <year>2019</year>
  <volume>7</volume>
  <fpage>80</fpage>
  <pub-id pub-id-type="doi">10.1186/s40425-019-0562-8</pub-id>
  <?supplied-pmid 30894212?>
  <pub-id pub-id-type="pmid">30894212</pub-id>
 </element-citation>
</ref>
